CAS RN: 957790-95-3
N-[(11bR)-2,6-di-9-anthracenyl-4-oxidodinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide
Product Availability
Choose a grade to view its available package options.
5 package records3 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260531 |
50mg / 100mg / 250mg |
Out of stock |
| 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250227 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251220 |
1g |
Out of stock |
| | Inquiry |
| Batchno.20250920 |
250mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250311 |
50mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS957790-95-3
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
957790-95-3 / N-[10,16-di(anthracen-9-yl)-13-oxo-12,14-dioxa-13lambda5-phosphapentacyclo[13.8.0.02,11.03,8.018,23]tricosa-1(15),2(11),3,5,7,9,16,18,20,22-decaen-13-yl]-1,1,1-trifluoromethanesulfonamide
Standard CAS: 957790-95-3
Multi CAS: No
Basic Information
CAS
957790-95-3
Multi CAS
No
Molecular Formula
C49F3H29NO5PS
Molecular Weight
831.800000
Exact Mass
831.145616
InChI
InChI=1S/C49H29F3NO5PS/c50-49(51,52)60(55,56)53-59(54)57-47-41(43-35-19-7-1-13-29(35)25-30-14-2-8-20-36(30)43)27-33-17-5-11-23-39(33)45(47)46-40-24-12-6-18-34(40)28-42(48(46)58-59)44-37-21-9-3-15-31(37)26-32-16-4-10-22-38(32)44/h1-28H,(H,53,54)
InChIKey
CMBHAQHNIGEHAM-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
60
Aromatic heavy atom count
48
Fraction Csp3
0.02
Rotatable bonds
4
H-bond acceptors
5
H-bond donors
1
Molar refractivity
234.76
TPSA
81.7
LogP / Solubility
WLOGP
13.93
MLOGP
12.33
XLogP3
14.1
Consensus LogP
13.45
Log S (ESOL)
-14.1
Class (ESOL)
Insoluble
Log S (Ali)
-16.43
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-17.1
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
2.09
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
8